Abstract
Follicular thyroid neoplasms are solitary nodules that present as a mass. Follicular adenomas are benign, encapsulated tumors with follicular differentiation that are more common in women, usually occur in adults, and are more common in areas of iodine deficiency. Follicular adenomas measure 1–3 cm and usually are smaller than follicular carcinomas, although size may overlap. Follicular neoplasms lack cytologic features of papillary thyroid carcinoma (PTC). Malignancy in follicular neoplasms requires capsular or vascular invasion. The capsule in follicular carcinomas often is thicker and more irregular than that of adenomas. Various histologic patterns, including microfollicular, macrofollicular, normofollicular, and trabecular growth, may be seen in follicular neoplasms. Areas of papillary architecture may be seen. Follicular neoplasms may have different cytomorphologies, including mucinous, signet ring cell, and clear cell, and may have intratumoral fat. Follicular neoplasms show immunopositivity for thyroid transcription factor 1 (TTF1), thyroglobulin, and keratin and are negative for chromogranin, synaptophysin, and calcitonin. Follicular neoplasms often show RAS mutations, and a few have t(2;3)(q13;p25) involving PAX8 and peroxisome proliferator-activated receptor-γ encoding a fusion protein. Follicular adenomas show increased expression of p27 cell cycle inhibitory protein and decreased Ki67 proliferative indices (LI) compared with follicular carcinomas, and carcinomas with metastases have higher Ki67 LI levels than those without. However, in an individual lesion, these and other immunohistochemical or molecular markers cannot separate benign from malignant follicular neoplasms definitively. Cytologic specimens cannot distinguish benign from malignant follicular neoplasms, as diagnosis of malignancy requires invasive growth. Follicular adenomas are treated with lobectomy and have an excellent prognosis. Follicular carcinomas show capsular and/or vascular invasion. Vascular invasion must occur within or beyond the capsule. Tumors with capsular invasion only (no vascular invasion) have more indolent behavior than those with vascular invasion. Follicular carcinomas with focal capsular and/or vascular invasion have been designated as minimally invasive, whereas those with more extensive invasion have been characterized as widely invasive, although this classification is being used less often. Tumors with extensive vascular invasion often are referred to as angioinvasive follicular carcinomas. Unlike PTC, which has frequent lymph node metastases, follicular carcinomas usually metastasize directly to viscera. Minimally invasive follicular carcinomas have a low mortality rate (3%–5% in some studies), and those with only capsular invasion (no vascular invasion) have a particularly good prognosis. Widely invasive carcinomas are aggressive, with a long-term mortality rate of 50 %.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs, World Health Organization classification of tumours. Lyon: IARC Press; 2004. p. 320.
Kroll TG, et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science. 2000;289(5483):1357–60.
Marques AR, et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab. 2002;87(8):3947–52.
Nikiforova MN, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88(5):2318–26.
Erickson LA, et al. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol. 1998;11(2):169–74.
van Heerden JA, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112(6):1130–6; discussion 1136–8.
Variakojis D, et al. Papillary clear cell carcinoma of the thyroid gland. Hum Pathol. 1975;6(3):384–90.
Landon G, Ordonez NG. Clear cell variant of medullary carcinoma of the thyroid. Hum Pathol. 1985;16(8):844–7.
Schroder S, Bocker W. Clear-cell carcinomas of thyroid gland: a clinicopathological study of 13 cases. Histopathology. 1986;10(1):75–89.
Ropp BG, et al. Follicular carcinoma of the thyroid with extensive clear-cell differentiation: a potential diagnostic pitfall. Diagn Cytopathol. 2000;23(3):222–3.
Heffess CS, Wenig BM, Thompson LD. Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases. Cancer. 2002;95(9):1869–78.
Carcangiu ML, Sibley RK, Rosai J. Clear cell change in primary thyroid tumors. A study of 38 cases. Am J Surg Pathol. 1985;9(10):705–22.
Vergilio J, Baloch ZW, LiVolsi VA. Spindle cell metaplasia of the thyroid arising in association with papillary carcinoma and follicular adenoma. Am J Clin Pathol. 2002;117(2):199–204.
Harsh M, Dimri P, Nagarkar NM. Osseous metaplasia and mature bone formation with extramedullary hematopoiesis in follicular adenoma of thyroid gland. Indian J Pathol Microbiol. 2009;52(3):377–8.
Pontikides N, et al. Extramedullary hemopoiesis in a thyroid nodule with extensive bone metaplasia and mature bone formation. Thyroid. 2003;13(9):877–80.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Erickson, L.A. (2014). Follicular Thyroid Neoplasms. In: Atlas of Endocrine Pathology. Atlas of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0443-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0443-3_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0442-6
Online ISBN: 978-1-4939-0443-3
eBook Packages: MedicineMedicine (R0)